Bristol-Myers Squibb Co. (BMY)
BCBA
Closed
Aug 24, 2026
Day's Range
35,480.0052 wk Range
19,980.00Profile - BMY - Bristol-Myers Squibb Co.
Profile
Mic Code
XBUE
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
32.50K
Bristol-Myers Squibb Co. is a globally renowned biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines. With a strong focus on serious diseases, the company's primary purpose is to address unmet medical needs in oncology, cardiovascular, immunoscience, and fibrosis through cutting-edge research and novel therapies. Bristol-Myers Squibb Co. is recognized for its portfolio of lifesaving medicines and commitment to patient-centric approaches, impacting various healthcare sectors including hospitals, private practices, and research institutions worldwide. The company's strategic collaborations and mergers, such as the notable acquisition of Celgene, have amplified its capabilities in biotechnology, bolstering its position as a leader in pharmaceuticals. Headquartered in New York City, Bristol-Myers Squibb Co. plays a pivotal role in the pharmaceutical market, steering advancements in medicine through continuous innovation and dedication to enhancing patient outcomes.
Profile Details
Type
Depositary Receipt
Ceo
Dr. Christopher S. Boerner Ph.D.
Address
Route 206 & Province Line Road
City
Princeton
State
NJ
Zip
08543
Country
United States
Phone
609 252 4621
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
